Evidence map›Paper›PMID 30272649›Full record

ArticleJournal of visualized experiments : JoVE2018

An Optimized Evans Blue Protocol to Assess Vascular Leak in the Mouse.

Marilee J Wick, Julie W Harral, Zoe L Loomis, Edward C Dempsey

Open access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Kinin BPharmaceuticals (Basel, Switzerland) · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. The Blood-Brain Barrier Is Unaffected in theInternational journal of molecular sciences · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Marilee J WickCardiovascular Pulmonary Research Laboratory, University of Colorado Denver; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver; Marilee.Wick@ucdenver.edu.
Julie W HarralCardiovascular Pulmonary Research Laboratory, University of Colorado Denver; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver.
Zoe L LoomisCardiovascular Pulmonary Research Laboratory, University of Colorado Denver; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver.
Edward C DempseyCardiovascular Pulmonary Research Laboratory, University of Colorado Denver; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver; Denver VA Medical Center.
University of Colorado Denver · US

Funding

VRAC and Rho in pulmonary EC proliferationP01HL014985 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI STENMARK, KURT R. · 1985 to 2019
$35.1M
Selected Peptidases and Pulmonary Vascular Remodeling in Chronic Obstructive PulmR03HL095439 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI DEMPSEY, EDWARD CHARLES · 2008 to 2009
$154k
NHLBI NIH HHS P01 HL014985NHLBI NIH HHS R03 HL095439
6 · The paper itself

Abstract

Vascular leak, or plasma extravasation, has a number of causes, and may be a serious consequence or symptom of an inflammatory response. This study may ultimately lead to new knowledge concerning the causes of or new ways to inhibit or treat plasma extravasation. It is important that researchers have the proper tools, including the best methods available, for studying plasma extravasation. In this article, we describe a protocol, using the Evans blue dye method, for assessing plasma extravasation in the organs of FVBN mice. This protocol is intentionally simple, to as great a degree as possible, but provides high quality data. Evans blue dye has been chosen primarily because it is easy for the average laboratory to use. We have used this protocol to provide evidence and support for the hypothesis that the enzyme neprilysin may protect the vasculature against plasma extravasation. However, this protocol may be experimentally used and easily adapted for use in other strains of mice or in other species, in many different organs or tissues, for studies which may involve other factors that are important in understanding, preventing, or treating plasma extravasation. This protocol has been extensively optimized and modified from existing protocols, and combines reliability, ease of use, economy, and general availability of materials and equipment, making this protocol superior for the average laboratory to use in quantifying plasma extravasation from organs.

Indexed as

AnimalsCapillary PermeabilityEvans BlueMaleMiceEvans Blue

Identifiers

PMID30272649
PMCPMC6235160
OpenAlexW2890190066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.